[ad_1]
Entry to specialty medication via industrial well being plans decreased from 2017 to 2021, and fewer than half of plans had been in step with FDA drug label indications, a latest research discovered. The Nationwide Pharmaceutical Council performed the research in partnership with the Middle for the Analysis of Worth and Threat in Well being at Tufts Medical Middle.
“Our research signifies that the usage of these restrictions is on the rise,” mentioned Rochelle R. Henderson, Ph.D., who led the research. “It’s important for employers, profit advisors and brokers to think about that these restrictions can hinder affected person entry to the therapies their clinicians prescribe and worsen their outcomes whereas rising well being system prices. Our research means that some payers may be doing the mathematics and never appreciating the downsides of putting hurdles in entrance of sufferers.”
[ad_2]
Source link